Hsa_circ_0000520 Overexpression Increases CDK2 Expression Via MiR-1296 to Facilitate Cervical Cancer Cell Proliferation
Overview
General Medicine
Affiliations
Background: Circular RNA (circRNA) has been demonstrated to participate in cervical cancer development. In this study, we analyzed the role of hsa_circ_0000520 in cervical cancer.
Methods: Fifty-two pairs of cervical cancer and adjacent normal tissue samples were collected, and five human cervical cancer cell lines were obtained followed by the detection of hsa_circ_0000520 expression. Nuclear-cytoplasmic isolation and fluorescence in situ hybridization were performed to analyze the subcellular localization of hsa_circ_0000520 while linear RNA was digested by RNase R. Gain- or loss-of function experiments on hsa_circ_0000520 were performed, followed by detection of cell proliferation and cell cycle by EdU, Cell Counting Kit-8, colony formation assay, and flow cytometry respectively.
Results: Hsa_circ_0000520 and cyclin-dependent kinase 2 (CDK2) were highly expressed in cervical cancer tissues. Binding sites between microRNA-1296 (miR-1296) and hsa_circ_0000520 or CDK2 were verified. Antibody to Argonaute 2 (Ago2) could precipitate hsa_circ_0000520, indicating that hsa_circ_0000520 could competitively bind to miR-1296 via Ago2. Silencing hsa_circ_0000520 inhibited cervical cancer cell proliferation and promoted the inhibitory effects of miR-1296 on CDK2, thereby blocking cell cycle progression and promoting apoptosis.
Conclusion: These results support the premise that targeting hsa_circ_0000520 can be a potential approach to combat cervical cancer.
Circular RNA NINL accelerates the malignant progression of cervical cancer.
Cao C, Zhang H, Zhang T, Nie C Discov Oncol. 2024; 15(1):766.
PMID: 39692846 PMC: 11655911. DOI: 10.1007/s12672-024-01588-8.
Zhang X, Cai W, Yan Y Anticancer Agents Med Chem. 2024; 24(18):1371-1381.
PMID: 39129291 DOI: 10.2174/0118715206305421240715042502.
Circular RNAs in Cell Cycle Regulation of Cancers.
Thamjamrassri P, Ariyachet C Int J Mol Sci. 2024; 25(11).
PMID: 38892280 PMC: 11173060. DOI: 10.3390/ijms25116094.
Hsa_circ_0000078 Regulates miR-205-5p/EREG Pathway to Inhibit Cervical Cancer Progression.
Liu C, Li Y Mol Biotechnol. 2023; 65(9):1453-1464.
PMID: 36645579 DOI: 10.1007/s12033-023-00658-6.
A review on the role of cyclin dependent kinases in cancers.
Ghafouri-Fard S, Khoshbakht T, Hussen B, Dong P, Gassler N, Taheri M Cancer Cell Int. 2022; 22(1):325.
PMID: 36266723 PMC: 9583502. DOI: 10.1186/s12935-022-02747-z.